Ye, Hongjian
Yang, Xiao
Yi, Chunyan
Guo, Qunying
Li, Yafang
Yang, Qiongqiong
Chen, Wei
Mao, Haiping
Li, Jianbo
Qiu, Yagui
Zheng, Xunhua
Zhang, Dihua
Lin, Jianxiong
Li, Zhijian
Jiang, Zongpei
Huang, Fengxian
Yu, Xueqing http://orcid.org/0000-0001-8624-744X
Funding for this research was provided by:
Natural Science Foundation of China (81774069, 81570614)
National Key Research and Development Program (2016YFC0906101)
Guangdong Science Foundation of China (2014B020212020, 2017A050503003, 2017B020227006)
Foundation of Guangdong Key Laboratory of Nephrology (2017B030314019)
Guangzhou Committee of Science and Technology, China (2014Y2-00543, 201704020167)
Science and Technology Planning Project of Guangdong Province of China (A2018353)
Article History
Received: 26 April 2018
Accepted: 3 June 2019
First Online: 2 July 2019
Ethics approval and consent to participate
: The study protocol was consistent with the ethical principles of the Helsinki Declaration and was approved by the Ethics Committee of The First Affiliated Hospital, Sun Yat-sen University. All participants were asked for permission to use their medical data for a non-commercial study, and written informed consent was obtained from them at the initiation of PD follow-up.
: Not applicable.
: The authors declare that they have no competing interests.